Application of penetration device (Tornus) for percutaneous coronary intervention in balloon uncrossable chronic total occlusion-procedure outcomes, complications, and predictors of device success.

Most patients with CTO are treated with optimal medical therapy (OMT) aimed at alleviating angina symptoms and improving clinical outcomes. Lack of robust supporting evidence is a main obstacle to ...

Doctors in Kolkata gave a 59-year-old man a new lease of life after he underwent a highly complex CTO-angioplasty using IVUS ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc., a California-based medical device company, announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has approved the ...

NATICK, Mass., Boston Scientific Corporation today announced the acquisition of two novel technologies to treat peripheral chronic total occlusions (CTOs). These acquisitions add technology platforms ...